![Robin Steele](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robin Steele
Direktor/Vorstandsmitglied bei
DARÉ BIOSCIENCE, INC.
Vermögen: 45 748 $ am 31.05.2026
Profil
Robin Joan Steele is currently Director at Nacuity Pharmaceuticals, Inc. since 2020, Director at Ancient Organics Bioscience, Inc. since 2019, Director at Alveo Technologies, Inc., Independent Director at Daré Bioscience, Inc. since 2017, and Director at Gladiator Biosciences, Inc. Former roles include Director at Alios BioPharma, Inc., Director at Targanta Therapeutics Corp.
from 2005 to 2007, Director at Ocuterra Therapeutics, Inc. from 2021 to 2024, Director at Coagulant Therapeutics, Inc. from 2021 to 2024, Secretary, Senior VP & General Counsel at InterMune, Inc. from 2012 to 2014, and Vice President-Commercial & Legal Affairs at Elan Pharmaceuticals LLC from 1998 to 2003.
Education includes undergraduate studies at The University of Colorado, graduate studies at the University of California, Hastings, and graduate studies at New York University School of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DARE BIOSCIENCE, INC. 0,14 % | 14.04.2026 | 20 515 ( 0,14 % ) | 45 748 $ | 31.05.2026 |
Aktive Positionen von Robin Steele
| Unternehmen | Position | Beginn |
|---|---|---|
| DARÉ BIOSCIENCE, INC. | Direktor/Vorstandsmitglied | 01.07.2017 |
Alveo Technologies, Inc.
 Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices | Direktor/Vorstandsmitglied | - |
Gladiator Biosciences, Inc. | Direktor/Vorstandsmitglied | - |
Nacuity Pharmaceuticals, Inc.
 Nacuity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Direktor/Vorstandsmitglied | 01.01.2020 |
Ehemalige bekannte Positionen von Robin Steele
| Unternehmen | Position | Ende |
|---|---|---|
Ocuterra Therapeutics, Inc.
 Ocuterra Therapeutics, Inc. Drugstore ChainsRetail Trade Manufactures drug products | Direktor/Vorstandsmitglied | 01.05.2024 |
Coagulant Therapeutics, Inc.
 Coagulant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat acute bleeding and unmet medical need that postpartum hemorrhage, intracranial hemorrhage, traumatic brain injury and trauma | Direktor/Vorstandsmitglied | 01.01.2024 |
| INTERMUNE INC | General Counsel | 01.01.2014 |
Targanta Therapeutics Corp.
 Targanta Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel antibacterial pro drugs | Direktor/Vorstandsmitglied | 31.12.2007 |
Elan Pharmaceuticals LLC
 Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | General Counsel | 01.04.2003 |
Ausbildung von Robin Steele
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
69
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Elan Pharmaceuticals LLC
Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Alios BioPharma, Inc.
 Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases | Health Technology |
Targanta Therapeutics Corp.
Targanta Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel antibacterial pro drugs | Health Technology |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Hastings
 University of California, Hastings Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ocuterra Therapeutics, Inc.
Ocuterra Therapeutics, Inc. Drugstore ChainsRetail Trade Manufactures drug products | Retail Trade |
New York University School of Law
 New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nacuity Pharmaceuticals, Inc.
Nacuity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Alveo Technologies, Inc.
Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices | Health Technology |
Daré Bioscience, Inc.
 Daré Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Gladiator Biosciences, Inc. | |
Coagulant Therapeutics, Inc.
Coagulant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat acute bleeding and unmet medical need that postpartum hemorrhage, intracranial hemorrhage, traumatic brain injury and trauma | Health Technology |
